homocysteine and rivastigmine

homocysteine has been researched along with rivastigmine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Bonham, J; Connelly, PJ; Cousland, G; Prentice, NP	1
Barone, P; Burn, DJ; Hsu, C; Lane, RM; Poewe, W; van Laar, T	1
Coutinho-Silva, R; Dos Santos, TM; Leite-Aguiar, R; Ramires Junior, OV; Savio, LEB; Silveira, JS; Wyse, ATS	1
Dos Santos, TM; Ferreira, FS; Gonçalves, CA; Ramires Júnior, OV; Silveira, JS; Vizuete, AFK; Wyse, ATS	1

Trials

2 trial(s) available for homocysteine and rivastigmine

Article	Year
A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:2 Topics: Aged; Alzheimer Disease; Analysis of Variance; Chi-Square Distribution; Cholinesterase Inhibitors; Dietary Supplements; Donepezil; Double-Blind Method; Female; Folic Acid; Folic Acid Deficiency; Galantamine; Homocysteine; Humans; Indans; Male; Mental Status Schedule; Phenylcarbamates; Piperidines; Placebos; Rivastigmine; Treatment Outcome; Vitamin B Complex; Vitamins	2008
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Movement disorders : official journal of the Movement Disorder Society, 2008, Aug-15, Volume: 23, Issue:11 Topics: Aged; Analysis of Variance; Dementia; Double-Blind Method; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Mental Status Schedule; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index	2008

Article

Year

A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.

International journal of geriatric psychiatry, 2008, Volume: 23, Issue:2

Topics: Aged; Alzheimer Disease; Analysis of Variance; Chi-Square Distribution; Cholinesterase Inhibitors; Dietary Supplements; Donepezil; Double-Blind Method; Female; Folic Acid; Folic Acid Deficiency; Galantamine; Homocysteine; Humans; Indans; Male; Mental Status Schedule; Phenylcarbamates; Piperidines; Placebos; Rivastigmine; Treatment Outcome; Vitamin B Complex; Vitamins

2008

Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.

Movement disorders : official journal of the Movement Disorder Society, 2008, Aug-15, Volume: 23, Issue:11

Topics: Aged; Analysis of Variance; Dementia; Double-Blind Method; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Mental Status Schedule; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index

2008

Other Studies

2 other study(ies) available for homocysteine and rivastigmine

Article	Year
Rivastigmine Reverses the Decrease in Synapsin and Memory Caused by Homocysteine: Is There Relation to Inflammation? Molecular neurobiology, 2022, Volume: 59, Issue:7 Topics: Acetylcholinesterase; Animals; Homocysteine; Hyperhomocysteinemia; Ibuprofen; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Rivastigmine; Synapsins	2022
Homocysteine May Decrease Glucose Uptake and Alter the Akt/GSK3β/GLUT1 Signaling Pathway in Hippocampal Slices: Neuroprotective Effects of Rivastigmine and Ibuprofen. Molecular neurobiology, 2023, Volume: 60, Issue:9 Topics: Animals; Glucose; Glucose Transporter Type 1; Glutathione; Glycogen Synthase Kinase 3 beta; Hippocampus; Homocysteine; Ibuprofen; Male; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Rivastigmine; Signal Transduction	2023

Article

Year

Rivastigmine Reverses the Decrease in Synapsin and Memory Caused by Homocysteine: Is There Relation to Inflammation?

Molecular neurobiology, 2022, Volume: 59, Issue:7

Topics: Acetylcholinesterase; Animals; Homocysteine; Hyperhomocysteinemia; Ibuprofen; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Rivastigmine; Synapsins

2022

Homocysteine May Decrease Glucose Uptake and Alter the Akt/GSK3β/GLUT1 Signaling Pathway in Hippocampal Slices: Neuroprotective Effects of Rivastigmine and Ibuprofen.

Molecular neurobiology, 2023, Volume: 60, Issue:9

Topics: Animals; Glucose; Glucose Transporter Type 1; Glutathione; Glycogen Synthase Kinase 3 beta; Hippocampus; Homocysteine; Ibuprofen; Male; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Rivastigmine; Signal Transduction

2023